Raltitrexed-induced hepatotoxicity: multivariate analysis of predictive factors

医学 雷蒂特雷塞德 内科学 中止 奥沙利铂 化疗 毒性 胃肠病学 天冬氨酸转氨酶 转氨酶 丙氨酸转氨酶 转氨酶升高 肌酐 癌症 肿瘤科 结直肠癌 碱性磷酸酶 生物化学 化学 酶
作者
Cristian Massacesi,Daniele Santini,Marco Rocchi,Annalisa La Cesa,F. Marcucci,Bruno Vincenzi,Stefano Delprete,Giuseppe Tonini,M. Bonsignori
出处
期刊:Anti-Cancer Drugs [Lippincott Williams & Wilkins]
卷期号:14 (7): 533-541 被引量:13
标识
DOI:10.1097/00001813-200308000-00005
摘要

Raltitrexed (Tomudex®; TOM) hepatotoxicity is usually characterized by a transient and self-limiting increase in transaminase levels. How this may condition daily clinical practice is still unclear. The aim of this study was to investigate predictive factors of TOM hepatotoxicity. In total, 130 patients were treated at two medical oncology institutions with TOM (3 mg/m2) (52 patients) or TOM plus oxaliplatin (TOMOX) (100 mg/m2 day 1 or 70 mg/m2 day 1, 8) (78 patients). A multinomial logistic regression (adjusted for multilevel data) was performed (on all administered chemotherapy courses) to assess the dependence of hepatic toxicity on a set of clinical factors correlated with patient, disease and treatment characteristics. Creatinine clearance was calculated by the Cockcroft formula before each chemotherapy course. Most of the patients presented colorectal cancer (95%) and metastatic disease (93%). Out of the 130 patients, 41 were aged 70 or more, while 119 (91.5%) had a good performance status (PS) (ECOG 0 or 1). Before chemotherapy, liver metastases were present in 78 (60%) patients and elevated transaminase in 25 (19%). A total of 584 courses were administered (252 TOM and 332 TOMOX). National Cancer Institute Common Toxicity Criteria grade 1/2 and 3/4 transaminase toxicity was observed in 62 and 20% of patients, respectively. To control transaminase increase, glutathione (GSH) or ademethionine (SAMe) was administered in 96 and 129 cycles, respectively. Hepatotoxicity conditioned delays (a week or more) in 60 (10%) chemotherapy cycles and was the reason for the discontinuation of chemotherapy in eight (6%) patients. Among the factors evaluated with multivariate analysis, sex, age, PS, creatinine clearance, previous chemotherapy treatment, presence of liver metastases and oncology centre were not significantly associated with TOM hepatotoxicity. Elevated baseline transaminase levels (p = 0.001), number of chemotherapy cycles (p<0.001), TOM cumulative dose (p = 0.018), unprolonged intervals between courses (p<0.001) and TOMOX regimen (p<0.001) emerged as factors predictive of hepatotoxicity. In the same analysis, GSH (p<0.001) and SAMe (p<0.001) were hepatoprotective agents. This study confirmed TOM-based hepatotoxicity as a clinical relevant side-effect and a major factor for treatment delays or discontinuation. Predictive and protective factors listed above could assist the management of this toxicity that has probably been underestimated until now.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
deckit完成签到 ,获得积分10
刚刚
Pluto发布了新的文献求助10
刚刚
初景发布了新的文献求助10
刚刚
吴大帅发布了新的文献求助10
刚刚
dede发布了新的文献求助10
1秒前
1秒前
1秒前
小c发布了新的文献求助10
1秒前
1秒前
李金玉发布了新的文献求助10
2秒前
2秒前
dididi发布了新的文献求助10
2秒前
xx完成签到,获得积分10
2秒前
路戳戳发布了新的文献求助10
2秒前
啁啾发布了新的文献求助10
2秒前
敏感的文龙完成签到,获得积分10
3秒前
CipherSage的应助被然然采纳,获得30
3秒前
snowman发布了新的文献求助10
3秒前
舒服的依玉完成签到,获得积分10
3秒前
无情幻枫完成签到,获得积分20
3秒前
清爽老九发布了新的文献求助10
3秒前
3秒前
勤劳洪纲发布了新的文献求助10
3秒前
4秒前
4秒前
七田皿完成签到,获得积分10
4秒前
廖紊发布了新的文献求助10
4秒前
4秒前
xx发布了新的文献求助10
5秒前
5秒前
大个的应助被Lysine采纳,获得10
6秒前
hhyy发布了新的文献求助10
6秒前
机智飞荷完成签到,获得积分10
6秒前
6秒前
HH发布了新的文献求助10
7秒前
7秒前
7秒前
7秒前
ding的应助被Yahooo采纳,获得10
7秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1500
John McDowells Bildungstheorie 800
Analyses de reconnaissances de dettes passées devant les échevins d'Ypres (1249-1291) 600
Handbook of Pharmaceutical Excipients. 9th ed 400
Synthesis, Application and Future Perspectives of Smart Nano-materials - Part 1 400
Breaking the World 300
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8154954
求助须知:如何正确求助?哪些是违规求助? 9551415
关于积分的说明 21704672
捐赠科研通 7744178
什么是DOI,文献DOI怎么找? 3425953
关于科研通互助平台的介绍 2551080
邀请新用户注册赠送积分活动 2469681